Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 250 of 559 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 03/01/20
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 10/10/20
End: 10/12/23
Due: 10/12/24
Phase: N/A
Priority: Normal
Start: 02/29/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 07/28/17
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 04/18/17
End: 10/01/18
Due: 10/01/19
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 10/31/10
Due: 10/31/11
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 12/31/13
Due: 12/31/14
Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 12/01/16
End: 12/01/19
Due: 12/01/20
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 06/01/22
End: 11/01/24
Due: 11/01/25
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 11/30/09
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 12/14/22
End: 03/10/24
Due: 03/10/25
Phase: N/A
Priority: Normal
Start: 02/28/20
End: 12/28/21
Due: 12/28/22
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 10/09/13
End: 09/25/14
Due: 09/25/15
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 05/17/21
End: 01/31/22
Due: 01/31/23